| __timestamp | Dr. Reddy's Laboratories Limited | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 176081000 |
| Thursday, January 1, 2015 | 62786000000 | 157939000 |
| Friday, January 1, 2016 | 62427000000 | 164073000 |
| Sunday, January 1, 2017 | 62453000000 | 169243000 |
| Monday, January 1, 2018 | 65724000000 | 168489000 |
| Tuesday, January 1, 2019 | 70421000000 | 172526000 |
| Wednesday, January 1, 2020 | 80591000000 | 200649000 |
| Friday, January 1, 2021 | 86645000000 | 237513000 |
| Saturday, January 1, 2022 | 100551000000 | 353358000 |
| Sunday, January 1, 2023 | 42907000000 | 586886000 |
| Monday, January 1, 2024 | 115557000000 |
Cracking the code
In the ever-evolving pharmaceutical and healthcare industry, understanding cost dynamics is crucial. Dr. Reddy's Laboratories Limited, a global pharmaceutical giant, and Lantheus Holdings, Inc., a leader in diagnostic imaging, present a fascinating study in contrasts. From 2014 to 2023, Dr. Reddy's Laboratories consistently reported a cost of revenue that dwarfed Lantheus Holdings by over 99%. This disparity highlights the scale and operational differences between the two companies. Notably, Dr. Reddy's Laboratories saw a significant increase in 2024, with costs surging by approximately 15% from 2022, while Lantheus Holdings' data for 2024 remains unavailable. This missing data underscores the challenges in financial forecasting and the importance of comprehensive data analysis. As the industry continues to grow, these insights provide a window into the financial strategies of leading companies.
Novo Nordisk A/S vs Lantheus Holdings, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.'s Expenses
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Iovance Biotherapeutics, Inc.
Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs MorphoSys AG
Analyzing Cost of Revenue: Lantheus Holdings, Inc. and Amphastar Pharmaceuticals, Inc.
Cost of Revenue Trends: Lantheus Holdings, Inc. vs Taro Pharmaceutical Industries Ltd.
Lantheus Holdings, Inc. vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored